Main description:

There can never be enough material in the public domain about cancers, and particularly breast cancer. This book adds much to the literature. It provides general information on breast cancer management and considers all new methods of diagnosis and therapy. It focuses on nuclear medicine modalities by comparing their results with other diagnostic and therapeutic approaches. The coverage provides readers with up-to-date knowledge on breast cancer as well as information on the advances in the field of diagnosis. It also details data on the development of some new modalities and provides a general overview of the available tools for breast cancer treatment.

Contents:

Histological classification of breast cancer.- Biomarkers for breast cancer.- Circulating tumour markers in breast cancer.- Axillary lymph node status in breast cancer patients:role of SPECT and pinhole SPECT with cationic lipophilic radiotracers.- Breast imaging with scintimammography.- Sentinel node detection in pre-operative axillary staging.- State of the art of current modalities for the diagnosis of breast lesions.- New Trend of MRI in the diagnosis of breast cancer.- Biological characterisation of breast cancer by means of PET.- 99mTc-MIBI in the evaluation of breast cancer biology.- The role of FDG-PET for axillary lymph node staging in primary breast cancer.- Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations.- FDG-PET in monitoring therapy of breast cancer.- FDG PET and tumour markers tests for the diagnosis of breast cancer.- Advantages and limitations of FDG PET in the follow-up of breast cancer .- PET/CT and breast cancer.- Current role of bone scan with phosphonates in the follow-up of breast cancer.- The progress in the treatment of early and advanced breast cancer.- 186Re-HEDP for metastatic bone pain in breast cancer patients.- 153Sm-EDTMP for bone pain treatemnt in skeletal metastases .-The choice of the correct imaging modality in breast cancer management.